Latest Breaking News On - Beijing based avistone - Page 1 : comparemela.com

Chinese biotechnology firm Avistone Pharmaceuticals has raised over $200 million in a series A round led by Vivo Capital in one of the largest such deals for the sector.

United statesHong kongPalo altoHongbo luHepeng shiAvistone pharmaceuticalsZai lab ltdPearl biotechnology coSinovac biotech ltdBolt biotherapeutics incVivo capitalBain capitalPrimavera capitalBeijing based avistonePearl biotechnologyGreater china